Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An 123I-metaiodobenzylguanidine SPECT/CT study

J Nucl Cardiol. 2020 Dec;27(6):2402-2409. doi: 10.1007/s12350-018-01545-3. Epub 2018 Dec 17.

Abstract

Purpose: The purpose of the study was to evaluate a novel approach for the quantification of right ventricular sympathetic dysfunction in patients diagnosed with ARVC/D through state-of-the-art functional SPECT/CT hybrid imaging.

Methods: Sympathetic innervation of the heart was assessed using 123I-MIBG-SPECT/CT in 17 patients diagnosed with ARVC according to the modified task force criteria, and in 10 patients diagnosed with idiopathic ventricular fibrillation (IVF). The 123I-MIBG-uptake in the left (LV) and right ventricle (RV) was evaluated separately based on anatomic information derived from the CT scan, and compared to the uptake in the mediastinum (M).

Results: There was a significant difference in the LV/M ratio between the ARVC/D and the IVF groups (3.2 ± 0.5 vs. 3.9 ± 0.8, P = 0.014), with a cut-off value of 3.41 (77% sensitivity, 80% specificity, AUC 0.78). There was a highly significant difference in the mean RV/M ratios between both groups (1.6 ± 0.3 vs. 2.0 ± 0.2, P = 0.001), with optimal cut-off for discrimination at 1.86 (88% sensitivity, 90% specificity, AUC 0.93).

Conclusion: Employing state-of-the-art functional SPECT/CT hybrid imaging, we could reliably assess and quantify right and left ventricular sympathetic innervation. The RV/M ratio was significantly lower in patients diagnosed with ARVC/D and provided sensitive and specific discrimination between patients with ARVC/D and IVF patients.

Keywords: ARVC; IVF; MIBG; Quantification; SPECT; Sympathetic innervation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Iodobenzylguanidine*
  • Area Under Curve
  • Arrhythmogenic Right Ventricular Dysplasia / diagnostic imaging*
  • Cardiomyopathies / diagnostic imaging*
  • Female
  • Heart Ventricles / diagnostic imaging*
  • Heart Ventricles / physiopathology
  • Humans
  • Male
  • Mediastinum / pathology
  • Middle Aged
  • Multimodal Imaging / methods*
  • Prospective Studies
  • ROC Curve
  • Sensitivity and Specificity
  • Sympathetic Nervous System
  • Tomography, Emission-Computed, Single-Photon / methods*
  • Tomography, X-Ray Computed / methods*
  • Ventricular Dysfunction, Right / diagnostic imaging*
  • Ventricular Fibrillation / diagnostic imaging
  • Ventricular Function, Right*

Substances

  • 3-Iodobenzylguanidine